Levetiracetam versus topiramate versus lamotrigine. A randomised study in newly diagnosed epilepsy.

Trial Profile

Levetiracetam versus topiramate versus lamotrigine. A randomised study in newly diagnosed epilepsy.

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Lamotrigine; Levetiracetam; Topiramate
  • Indications Epilepsy
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 22 Oct 2011 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
    • 22 Oct 2011 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network record.
    • 28 Jul 2010 Planned end date changed from 27 Jan 2009 to 2 Oct 2009 as reported by United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top